Thomas Balland serves as Executive at EYEGATE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Thomas Balland has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 28, 2015 involved receiving (via award) 5,037 shares valued at $0.
Thomas Balland currently holds 10,422 shares of EYEGATE PHARMACEUTICALS INC (EYEG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Balland has been a net neutral trader of EYEG stock. They have purchased $0 and sold $0 worth of shares.
Thomas Balland's most recent insider trade was on Aug 28, 2015, when they sold 5,037 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |